Financial StabilityThe balance sheet is solid with a significant cash reserve, indicating no immediate liquidity risk for Sight Sciences.
Market OpportunityOMNI still has potential to take market share in the underpenetrated standalone market, providing some upside opportunity.
Revenue Growth PotentialTearCare submissions are ongoing, and payor wins could occur which would likely catalyze Dry Eye revenue growth.